investors.adverum.comInvestor Overview | Adverum Biotechnologies, Inc.
investors.adverum.com Profile
investors.adverum.com
Maindomain:adverum.com
Title:Investor Overview | Adverum Biotechnologies, Inc.
Description：Skip to main navigation Home Company Our Mission Core Values Our Leadership Team Contact Us Pipeline Pipeline ADVM-022 for Wet AMD ADVM-022 for DME Publications Platform Novel Vector Discovery Manufac
Discover investors.adverum.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investors.adverum.com Information
| Website / Domain: | investors.adverum.com |
| HomePage size: | 60.042 KB |
| Page Load Time: | 0.15325 Seconds |
| Website IP Address: | 23.194.131.146 |
| Isp Server: | Akamai Technologies Inc. |
investors.adverum.com Ip Information
| Ip Country: | United States |
| City Name: | Ashburn |
| Latitude: | 39.043720245361 |
| Longitude: | -77.487487792969 |
investors.adverum.com Keywords accounting
| Keyword | Count |
|---|
investors.adverum.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1608742333" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Wed, 23 Dec 2020 16:52:13 GMT |
| Link: http://investors.adverum.com/; rel="shortlink", http://investors.adverum.com/; rel="canonical", https://investors.adverum.com/investor-overview; rel="alternate"; hreflang="en", https://investors.adverum.com/investor-overview; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| X-Age: 216 |
| X-Cache-Hits: 1 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Request-ID: v-34e55d4e-453f-11eb-a60d-2b0ab0feafe1 |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 12264 |
| X-EdgeConnect-MidMile-RTT: 0, 19 |
| X-EdgeConnect-Origin-MEX-Latency: 24, 24 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Wed, 23 Dec 2020 16:55:50 GMT |
| Date: Wed, 23 Dec 2020 16:55:50 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
| Strict-Transport-Security: max-age=15768000 ; preload |
investors.adverum.com Meta Info
| charset="utf-8"/ |
| content="Adverum Biotechnologies, Inc." property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
23.194.131.146 Domains
| Domain | WebSite Title |
|---|
investors.adverum.com Similar Website
| Domain | WebSite Title |
|---|---|
| Investor Overview | Adverum Biotechnologies, Inc. | |
| Adverum Biotechnologies | |
| SBOT Stock Forecast Price & News Stellar Biotechnologies | |
| Custom Oligonucleotide Synthesis & Reagents | TriLink Biotech | TriLink BioTechnologies | |
| Nelnet Inc - Investor Resources - Investor Services Program | |
| Winnebago Investor Relations Investor Home | |
| Exantas Investor Relations - Investor Overview | |
| Universal Technical Institute's Investor Relations - UTI Investor Relations | |
| Choice Hotels International - Investor Relations Home - Investor Relations | |
| Equitable Bank Investor Relations - Investor Relations - Overview | |
| Investor Relations - American Express Investor Relations | |
| 51Talk Investor Relations - Investor Relations Home | |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations | |
| Lankan Investor - Lankan Investor - Home | |
| Investor Relations | Investor Relations | Littelfuse |
investors.adverum.com Traffic Sources Chart
investors.adverum.com Alexa Rank History Chart
investors.adverum.com Html To Plain Text
Skip to main navigation Home Company Our Mission Core Values Our Leadership Team Contact Us Pipeline Pipeline ADVM-022 for Wet AMD ADVM-022 for DME Publications Platform Novel Vector Discovery Manufacturing Process Careers We Care About You Jobs Media Press Releases Investors Contact Us Investors Investor Overview JP Morgan Virtual HC Conference Jan 13, 2021 10:50 am EST November 2020 Corporate Presentation Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum’s core capabilities include clinical development, novel vector discovery and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control. Adverum Biotechnologies NASDAQ: 12/23/20 11:52 AM EST Data provided by Nasdaq. Minimum 15 minutes delayed. Recent News Dec 14 2020 Summary Toggle Adverum Biotechnologies Appoints Pharmaceutical Industry Veteran Dawn Svoronos to Board of Directors Nov 23 2020 Summary Toggle Adverum Biotechnologies Presents at the Piper Sandler Annual Virtual Healthcare Conference Nov 14 2020 Summary Toggle Adverum Biotechnologies Announces Positive Interim Data from Cohorts 1-4 from OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD Nov 5 2020 Summary Toggle Adverum Biotechnologies Reports Recent Business Progress and Third Quarter 2020 Financial Results View All Upcoming Events Category Committee Charters Governance Documents Year - Any - 2021 2020 2019 2018 2017 2016 2015 2014 Date Event Details Summary Toggle Jan 13, 2021 at 10:50 AM EST JP Morgan Virtual HC Conference View Webcast View All Investor Relations Investor Overview Stock Information Stock Quote Stock Chart Analyst Coverage Press Releases Events and Presentations Financial Statements and SEC Filings SEC Filings Annual Reports and Proxy Statements Corporate Governance Governance Highlights Management Team Board of Directors Contact the Board Shareholder Services Investor FAQs E-mail Alerts Contact Us Shareholder Tools Print Page RSS Feeds Email Alerts Company Company Our Mission Core Values Our Leadership Team Contact Us Pipeline Pipeline wAMD DME Publications Platform Platform Novel Vector Discovery Manufacturing Process Careers Careers We Care About You Jobs Media Media Press Releases Investors Investors Stock Information Press Releases Events & Presentations Financial Statements & SEC Filings Corporate Governance Shareholder Services Contact Us © Adverum Biotechnologies, Inc. All rights reserved. Privacy Policy Community Guidelines...
investors.adverum.com Whois
"domain_name": [
"ADVERUM.COM",
"adverum.com"
],
"registrar": "GoDaddy.com, LLC",
"whois_server": "whois.godaddy.com",
"referral_url": null,
"updated_date": [
"2020-04-11 12:09:44",
"2020-04-11 05:09:43"
],
"creation_date": [
"2002-04-10 15:15:06",
"2002-04-10 10:15:06"
],
"expiration_date": [
"2021-04-10 15:15:06",
"2021-04-10 10:15:06"
],
"name_servers": [
"DNS1.EASYDNS.COM",
"DNS2.EASYDNS.NET",
"DNS3.EASYDNS.CA"
],
"status": [
"clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited",
"clientRenewProhibited https://icann.org/epp#clientRenewProhibited",
"clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited",
"clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited",
"clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited",
"clientRenewProhibited http://www.icann.org/epp#clientRenewProhibited",
"clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited"
],
"emails": "abuse@godaddy.com",
"dnssec": "unsigned",
"name": null,
"org": "Avalanche Biotechnologies, Inc.",
"address": null,
"city": null,
"state": "California",
"zipcode": null,
"country": "US"